ABL Bio Inc (298380) — Free Cash Flow Generation Index

Latest as of March 2026: 0.99x

ABL Bio Inc (298380) has a Free Cash Flow Generation Index of 0.99x as of March 2026. Free cash flow of ₩32.60 Billion represents 1% of operating cash flow (₩32.84 Billion). Explore how much does ABL Bio Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.99x

Free Cash Flow / Operating CF

Free Cash Flow

₩32.60 Billion

KRW

Operating Cash Flow

₩32.84 Billion

KRW

Capital Expenditures

₩243.74 Million

KRW

ABL Bio Inc Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for ABL Bio Inc across 1 annual periods. For the full cash flow conversion analysis, see ABL Bio Inc operating cash flow efficiency.

Annual Free Cash Flow Generation for ABL Bio Inc (2022–2022)

Year-by-year Free Cash Flow Generation Index for ABL Bio Inc. Check 298380 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2022	0.95x	₩68.49 Billion	₩72.13 Billion	₩2.06 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).